resveratrol has been researched along with Myelodysplastic Syndromes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Xu, S; Ying, Y; Zhou, R; Zhou, W | 1 |
1 other study(ies) available for resveratrol and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Resveratrol Suppresses Growth and Migration of Myelodysplastic Cells by Inhibiting the Expression of Elevated Cyclin D1 (CCND1).
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Case-Control Studies; Cell Cycle; Cell Movement; Cell Proliferation; Cyclin D1; Gene Expression Regulation; Humans; Myelodysplastic Syndromes; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2017 |